4/30/19: Official Launches of TearCare ® and the Enhanced, Next Generation OMNI ® System is Launched by Sight Sciences

AlixPartners Forecasts: Household Products Could Cost U.S. Manufacturers and Consumers 15% More This Year Due to Resin Shortage

While companies can’t control the market forces at play, they can take action to mitigate the risk and impact of supply chain disruption.

How To Control a Radio Frequency (RF) Process

The radio frequency welding and manufacturing process uses electromagnetic energy and pressure to fuse and permanently bond vinyl, thermoplastic, and coated materials to produce a specific product - all according to customer requirements. Using this RF sealing process, a distinct, one-piece perpetual bond is formulated that is both solid and resistant to ripping or tearing. But how is this process controlled, and with what specific tools? Read on.

Sight Sciences, Inc. today announced the official commercial launch of TearCare ® as well as the introduction of their aesthetically and ergonomically enhanced OMNI ® Surgical System (initially launched in February 2018).

Sight Sciences is a growth-stage medical device company transforming the two fastest growing segments in ophthalmology and optometry – dry eye and glaucoma.

Paul Badawi, Founder and CEO of Sight Sciences commented, “We are excited to launch these two innovative products that can transform the way surgeons and eye care professionals target the underlying cause of two of the world’s most prevalent eye diseases.:  He added, “We have been thrilled with the market receptivity to our first-generation OMNI® system, which we have been selling since early 2018 through our world class surgical commercial team built from the ground up by Shawn O’Neil, our Chief Commercial Officer. Given Shawn’s long history of developing and leading high-performance teams in both surgical devices and vision care, we are excited to replicate this success with the commercial launch of TearCare®,” said

New TearCare ® System is the world’s first and only wearable device providing a personalized open-eye experience for dry eye disease treatment.

“First and foremost, our surgical and vision care teams fully appreciate the clinical value of the groundbreaking products we are bringing to our MD and OD customer bases. We have built a highly robust and pedigreed commercial force comprised of two discrete, specialized sales and marketing teams for both the Dry Eye (TearCare®) and MIGS (OMNI®) practice areas. We are well-positioned to further accelerate the market adoption of OMNI® in the coming months as we roll out our next generation product and to execute a best-in-class commercial launch for TearCare®. As we penetrate and expand these two substantial, rapidly growing markets over the coming years, our goal is to be amongst the top performing companies in ophthalmology as well as MedTech more broadly,” said Shawn O’Neil, Chief Commercial Officer of Sight Sciences.

The rollout of the new devices will include product demonstrations, presentations and events at a number of the eye care industry’s upcoming premier shows, including:

  • Vision Source Exchange, held May 1-4 in Tampa, FL, at booth #1129.
  • American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators (ASCRS/ASOA) annual meetings, held May 3-7 in San Diego, CA, at booth #1307.
  • American Optometric Association (AOA) annual meeting, held June 19-23 in St. Louis, MO, at booth #1215.


Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.